Galvin stated: “I am honored to contribute to the tremendous impact Maryland Tech Council is making in the state. It is an important enabler for biotech and technology -- two industries that have huge potential economic impact for the state. It’s been a great experience to be a member for these past years, the Maryland Tech Council has made a positive impact on AGT. I see this appointment as an opportunity to give back to the important work Tami Howie and her team are doing to help build strong technology and life science companies in Maryland.”
Galvin is a veteran member of the Maryland Tech Council and has been involved in its recent progress. He participated in various activities with the Maryland Tech Council, including: jointly testifying before the Maryland Senate Finance Committee against generic drug price control legislation that could curtail Marylander’s access to drugs (SB1023); participating as a featured member at Maryland Tech Council's BIO International Conference; and sponsoring or participating in its other events, such as TEDCO’s Innovation Challenge, MTC Industry Awards, East Coast VentureCON, and the Bio+Tech18 Conference.
Tami Howie, CEO of Maryland Tech Council, announced: “As a 12-year veteran in the biotech industry in Maryland having decades of experience in Silicon Valley in the tech industry, we are excited to have Jeff Galvin join our Board of Directors. His strong experience and success in both tech and biotech will be instrumental to the work we do to foster a healthy biotech and technology ecosystem in Maryland. His mission and experience are closely linked to what we are creating in Maryland and we see his participation as an asset for the Council.”
Howie is a key opinion leader in Maryland’s biotech and technology industries. For the past 20 years, Howie has helped technology companies grow in the Mid-Atlantic region and nationwide. She has been involved with the successful exits of over 150 companies and has represented technology companies, investors, SBICs and underwriters such as JP Morgan, Goldman Sachs and Morgan Stanley. Howie and Galvin share a common passion for developing the tremendous potential of the biotechnology and technology industries in Maryland to dramatically increase the economy and business ecosystem. Maryland Tech Council published the following press release announcing 2018 appointments to the board: http://bit.ly/2OK3zsC
About American Gene Technologies (AGT):
AGT is an emerging gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications including large and orphan indications, infectious diseases, immune-oncology, and monogenic disorders. AGT expects to take its patented, lead candidate for an HIV Cure into the clinic in 2019. It has pioneered a novel immuno-oncology approach of stimulating gamma-delta (γδ) T cells to attack a variety of cancers. Four key patents in AGT’s novel immuno-oncology approach have been granted. AGT has a diverse portfolio of patent filings surrounding key tools and components in viral vectors, gene therapy, and regenerative medicine.
Clicking the image will take you to the original article